Latest California Healthline Stories
Germany’s pharmacies provide insights into the country’s low drug prices and strict regulations. But they’re still businesses.
People with diabetes say they’ve been waiting for years for better technology to manage their chronic condition. Tired of waiting, some tech-savvy, do-it-yourselfers are constructing their own devices using open-source programming instructions.
A growing number of pregnant women are among the migrants seeking asylum in the United States. Many must wait in Mexico until their cases are heard, spending weeks or months in migrant shelters with limited access to health care.
Hundreds of protesters descended on the state Capitol on Thursday, warning against government tyranny and corporate greed. Their target: not taxes, not high-tech surveillance, but a bill that would determine which kids must get their routine shots.
The Senate Health, Education, Labor and Pensions Committee is scheduled next week to mark up a massive legislative package on curbing health costs, but some of the details remain unresolved, including what formula to use to pay doctors and hospitals involved in surprise medical bills.
At Wednesday’s House Budget Committee, Congressional Budget Office experts outlined the complexities of implementing an overhaul of America’s health insurance system.
During a hearing Tuesday, panel members focused on how drug companies have used patents to allegedly protect their competitive edge and profits.
In an unusual move, the House Rules Committee, instead of one of the panels that typically oversee health policy, held the first House hearing in a decade about converting the U.S. to a government-financed health care system.
Asylum seekers from Mexico and Central America, housed in migrant shelters in the border city of Tijuana, Mexico, are often sick and exhausted from their long journeys. Volunteer health workers from Southern California recently sent a mobile clinic to one of those shelters and spent a day tending to its inhabitants.
During Wednesday’s House subcommittee hearing on insulin price hikes, drug makers and benefits managers pointed fingers at each other for the last decade’s 300% price increase, frustrating congressional representatives.